Impact of Sarcopenia and Inflammation on Patients with Advanced Non-Small Cell Lung Cancer (NCSCL) Treated with Immune Checkpoint Inhibitors (ICIs): A Prospective Study

Impact of Sarcopenia and Inflammation on Patients with Advanced Non-Small Cell Lung Cancer (NCSCL) Treated with Immune Checkpoint Inhibitors (ICIs): A Prospective Study

Background: Sarcopenia is a condition characterized by loss of skeletal muscle mass associated with worse clinical outcomes in cancer patients. Data on sarcopenia in patients undergoing immune checkpoint inhibitors (ICI) therapy are still limited. The aim of this prospective observational study was...

Full description

Bibliographic Details
Main Authors: Marta Tenuta, Alain Gelibter, Carla Pandozzi, Grazia Sirgiovanni, Federica Campolo, Mary Anna Venneri, Salvatore Caponnetto, Enrico Cortesi, Paolo Marchetti, Andrea M. Isidori, Emilia Sbardella
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:Cancers
Subjects:
sarcopenia
lung cancer
immunotherapy
PDL1
biomarker
Online Access:https://www.mdpi.com/2072-6694/13/24/6355

Internet

https://www.mdpi.com/2072-6694/13/24/6355

Similar Items